Jiangzhong Pharmaceutical Co Ltd - Asset Resilience Ratio

Latest as of December 2025: 1.38%

Jiangzhong Pharmaceutical Co Ltd (600750) has an Asset Resilience Ratio of 1.38% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read 600750 total debt and obligations for a breakdown of total debt and financial obligations.

Liquid Assets

CN¥95.10 Million

≈ $13.92 Million USD Cash + Short-term Investments

Total Assets

CN¥6.88 Billion

≈ $1.01 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (1997–2025)

This chart shows how Jiangzhong Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. See Jiangzhong Pharmaceutical Co Ltd (600750) shareholders funds for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Jiangzhong Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Jiangzhong Pharmaceutical Co Ltd stock valuation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥95.10 Million	1.38%
Total Liquid Assets	CN¥95.10 Million	1.38%

Asset Resilience Insights

Limited Liquidity: Jiangzhong Pharmaceutical Co Ltd maintains only 1.38% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Jiangzhong Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio

Compare Jiangzhong Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	Drug Manufacturers - Specialty & Generic	4.94%
Zhejiang Huahai Pharmaceutical Co Ltd SHG:600521	Drug Manufacturers - Specialty & Generic	0.44%
Emcure Pharmaceuticals Ltd NSE:EMCURE	Drug Manufacturers - Specialty & Generic	1.38%
Guangdong Zhongsheng Pharmaceutical Co Ltd SHE:002317	Drug Manufacturers - Specialty & Generic	6.62%
Ningbo Menovo Pharm Co Ltd SHG:603538	Drug Manufacturers - Specialty & Generic	2.69%
Swedish Orphan Biovitrum AB (publ) ST:SOBI	Drug Manufacturers - Specialty & Generic	1.54%
Changzhou Qianhong Biopharma Co Ltd SHE:002550	Drug Manufacturers - Specialty & Generic	20.24%
Hunan Warrant Pharmaceutical Co. Ltd. A SHG:688799	Drug Manufacturers - Specialty & Generic	0.40%

Annual Asset Resilience Ratio for Jiangzhong Pharmaceutical Co Ltd (1997–2025)

The table below shows the annual Asset Resilience Ratio data for Jiangzhong Pharmaceutical Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	1.38%	CN¥95.10 Million ≈ $13.92 Million	CN¥6.88 Billion ≈ $1.01 Billion	+1.23pp
2024-12-31	0.15%	CN¥10.01 Million ≈ $1.46 Million	CN¥6.51 Billion ≈ $952.32 Million	-0.63pp
2023-12-31	0.78%	CN¥50.02 Million ≈ $7.32 Million	CN¥6.40 Billion ≈ $936.73 Million	-21.09pp
2022-12-31	21.87%	CN¥1.37 Billion ≈ $200.89 Million	CN¥6.28 Billion ≈ $918.41 Million	-6.93pp
2021-12-31	28.81%	CN¥1.73 Billion ≈ $252.82 Million	CN¥6.00 Billion ≈ $877.64 Million	+8.88pp
2020-12-31	19.92%	CN¥980.89 Million ≈ $143.54 Million	CN¥4.92 Billion ≈ $720.47 Million	+6.18pp
2019-12-31	13.74%	CN¥654.07 Million ≈ $95.71 Million	CN¥4.76 Billion ≈ $696.42 Million	-9.83pp
2018-12-31	23.58%	CN¥899.96 Million ≈ $131.69 Million	CN¥3.82 Billion ≈ $558.54 Million	+23.50pp
2003-12-31	0.08%	CN¥800.00K ≈ $117.07K	CN¥986.94 Million ≈ $144.42 Million	-1.33pp
2000-12-31	1.41%	CN¥10.00 Million ≈ $1.46 Million	CN¥708.47 Million ≈ $103.67 Million	-1.01pp
1997-12-31	2.42%	CN¥9.98 Million ≈ $1.46 Million	CN¥412.00 Million ≈ $60.29 Million	--

pp = percentage points

About Jiangzhong Pharmaceutical Co Ltd

SHG:600750 China Drug Manufacturers - Specialty & Generic

Market Cap

$2.23 Billion

CN¥15.22 Billion CNY

Market Cap Rank

#5931 Global

#1277 in China

Share Price

CN¥23.94

Change (1 day)

+0.08%

52-Week Range

CN¥21.21 - CN¥27.69

All Time High

CN¥561.13